tadalafil has been researched along with Hypotension in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denne, J; Emmick, JT; Hutter, AM; Jackson, G; Kloner, RA; Mitchell, MI | 1 |
Kloner, RA | 1 |
Prisant, LM | 1 |
Jung, F; Leithäuser, B; Park, JW | 1 |
2 review(s) available for tadalafil and Hypotension
Article | Year |
---|---|
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents | 2004 |
Phosphodiesterase-5 inhibitors and their hemodynamic effects.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Blood Pressure; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Hypotension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vascular Resistance | 2006 |
2 trial(s) available for tadalafil and Hypotension
Article | Year |
---|---|
Time course of the interaction between tadalafil and nitrates.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carbolines; Contraindications; Cross-Over Studies; Double-Blind Method; Drug Synergism; Erectile Dysfunction; Humans; Hypotension; Male; Middle Aged; Nitrates; Phosphodiesterase Inhibitors; Tadalafil; Time Factors | 2003 |
Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition.
Topics: Administration, Sublingual; Adult; Angina Pectoris; Blood Pressure; Carbolines; Cardiovascular Diseases; Dosage Forms; Drug Interactions; Erectile Dysfunction; Humans; Hypotension; Male; Nitrendipine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil | 2008 |